21 Jun 2017 12:10
Consort Medical plc
Director Shareholding
21 June 2017
Consort Medical plc (the 'Company') announces that Paul Hayes, Chief Financial Officer purchased 4,000 ordinary 10p shares at a price of £10.9445 per share on 20 June 2017. Following this transaction Mr Hayes holds 8,000 ordinary shares in the Company.
The Notification of Dealing Form set out below is provided in accordance with the requirements of the Market Abuse Regulation.
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
a)
| Name
| Paul Hayes
| |||
2
| Reason for the notification
| ||||
a)
| Position/status
| Chief Financial Officer | |||
b)
| Initial notification /Amendment
| Initial Notification | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
| Name
| Consort Medical plc
| |||
b)
| LEI
| 2138001TBP74FD66QT38 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
a)
| Description of the financial instrument, type of instrument | Ordinary Shares of 10p each | |||
Identification code | ISIN: GB0000946276 | ||||
b)
| Nature of the transaction
| Acquisition | |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
£10.9445 | 4,000 | ||||
d)
| Aggregated information | ||||
n/a single transaction | |||||
- Aggregated volume | |||||
- Price | |||||
e)
| Date of the transaction
| 2017-06-20 | |||
f)
| Place of the transaction
| London Stock Exchange Main Market (XLon) | |||
Enquiries: Michelle Palmer, Assistant Company Secretary 01442 8867920
Consort Medical plc is a leading, global, single source pharma services drug and delivery device company. We are at the leading edge of innovation and we are committed to investing in patient, clinician and customer driven innovation to create new treatments, new markets and new opportunities.
Our businesses
Bespak is a global market leader in the manufacture of drug delivery devices for pharmaceutical partner companies, including respiratory, nasal, injectables and ocular products, and the manufacture of devices for the point of care diagnostics market. www.bespak.com.
Aesica is a leading provider of finished dose and active pharmaceutical ingredient (API) development and manufacturing services to pharmaceutical partners. www.aesica-pharma.com.
We employ more than 2000 people globally of which 1400 are located in the UK. We have UK facilities in King's Lynn, Cambridge, Nelson, Milton Keynes, Cramlington, Queenborough and Hemel Hempstead, German facilities in Monheim and Zwickau and a facility in Pianezza, Italy. Consort Medical is a public company quoted on the premium list of the London Stock Exchange (LSE: CSRT). www.consortmedical.com.